Senior Manager, Commercial Insights & Strategy jobs in United States
cer-icon
Apply on Employer Site
company-logo

REGENXBIO · 1 day ago

Senior Manager, Commercial Insights & Strategy

REGENXBIO is a company focused on developing novel AAV gene therapies. As a Senior Manager, Commercial Insights & Strategy, you will serve as a strategic thought partner, connecting competitive intelligence and market research to shape marketing strategy and advance insights capabilities.

BiopharmaBiotechnologyGeneticsTherapeutics

Responsibilities

Lead development and communication of integrated insights across teams to guide near- and long-term strategy
Synthesize market research, competitive intelligence, and field feedback into clear, actionable insights that inform brand planning, launch readiness, and marketing strategy
Help shape branding, messaging, and market metrics including awareness, perception, and adoption intent
Lead proactive monitoring of the program, gene therapy, and rare disease landscapes, including REGENXBIO licensees and competitors, to inform commercial strategy and brand planning
Coordinate and facilitate competitive intelligence collection at major medical conferences in partnership with Medical Affairs and Commercial teams, ensuring timely debriefs and actionable insights
Work with cross-functional partners to refine forecasts and scenario planning to inform strategic decisions
Integrate epidemiology, market dynamics, and insights data to support portfolio and program-level assumptions
Manage vendor partnerships for market research, analytics, and CI to ensure high-quality, actionable deliverables on time and within budget
Support development of a scalable insights and analytics technology stack for commercial use
Engage with senior stakeholders across Commercial, R&D, and Corporate Development to communicate insights and recommendations that influence decision-making
Present findings and implications in clear, concise formats tailored to different audiences
Travel up to 25%

Qualification

Commercial insightsMarket researchCompetitive intelligenceForecastingBrand strategyDrug developmentGene therapyAnalytical skillsVendor managementStakeholder engagementExcelPowerPointCI/MR databasesCommunication skillsCross-functional collaborationProblem-solvingSelf-starterOrganizational skillsPresentation skills

Required

Bachelor's degree required; advanced degree (MS, PhD, MBA) in life sciences, business, or healthcare field preferred
5+ years of experience in commercial insights, market research, competitive intelligence, forecasting, or marketing within the biotech or pharmaceutical industry
Proven experience supporting or leading activities related to product launch preparation, including market assessments, forecasting, brand strategy, or field enablement
Strong understanding of drug development and commercialization processes, ideally within rare disease or gene therapy
Demonstrated ability to integrate primary (qualitative and quantitative) and secondary research into clear strategic recommendations
Excellent written and verbal communication skills with the ability to influence and engage stakeholders across all levels of the organization
Track record of cross-functional collaboration with marketing, medical, market access, and field teams
Highly organized self-starter with strong analytical and problem-solving skills and comfort operating in ambiguity
Proficient with Excel, PowerPoint, and CI/MR databases and tools such as Citeline, BioMedtracker, EvaluatePharma, PubMed, and clinicaltrials.gov
Experience managing vendors and external partners to deliver high-quality insights and analyses on time and within budget

Preferred

Experience in gene therapy, retinal diseases, or rare diseases strongly preferred

Benefits

Market-competitive salaries
Annual bonus program
Education assistance
Retirement plan with employer match
Stock options at all levels
Summer hours

Company

REGENXBIO

twittertwittertwitter
company-logo
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.

Funding

Current Stage
Public Company
Total Funding
$928.19M
Key Investors
Vivo Capital
2025-05-19Post Ipo Debt· $150M
2024-03-06Post Ipo Equity· $140M
2021-01-06Post Ipo Equity· $230.3M

Leadership Team

leader-logo
Curran Simpson
President and CEO
linkedin
leader-logo
Francesca Cook
Vice President, Global Pricing and Market Access
linkedin
Company data provided by crunchbase